Search

everythinglearnresearchcommunity

for

Search:↓

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Vesicular carriers like liposomes may improve cosmetic skin treatment delivery and effectiveness but need more human research.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

Micro-current stimulation may promote hair growth more effectively than standard treatments.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

Early treatment helps stop hair loss in women of color.

Pumpkin seed oil may improve prostate health, bladder control, and hair growth in men.

Laser-assisted drug delivery improves hair loss.

Topical minoxidil improves female pattern hair loss, finasteride not effective, laser devices show mixed results.